X-Linked Agammaglobulinemia (XLA) Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
SARS-CoV-2 infection has significantly contributed to morbidity and mortality in patients with primary humoral immunodeficiencies, such as those with X-linked agammaglobulinemia (XLA) and common variable immunodeficiency (CVID). Currently, there is insufficient data to determine if mRNA vaccination and/or previous COVID-19 infection confers protection against rapidly mutating SARS-CoV-2 variants in patients with primary humoral immunodeficiencies. Evaluation of T-cell specific immune responses following vaccination against SARS-CoV-2 and omicron variant specific COVID-19 infection may help elucidate underlying mechanisms o...
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: David Sanchez, Lin Radigan, Charlotte Cunningham-Rundles Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
Relapsing < em > Helicobacter cinaedi < /em > Cellulitis without Bacteremia in a Patient with X-linked Agammaglobulinemia after 1 Year of Antibiotic Prophylaxis
Skinmed. 2022 Dec 20;20(6):457-459. eCollection 2022.ABSTRACTA 23-year-old man with Bruton's X-linked agammaglobulinemia (XLA), who required intravenous immunoglobulin G (IgG) every 3 weeks, presented with an erythematous scaly eruption adjacent to the chest port for antibiotic therapy (Figures 1A,B). His past medical history included Helicobacter cinaedi cellulitis in 2015 that was treated with intravenous vancomycin and ertapenem with no improvement after several months. The therapy was switched to ertapenem and amikacin, which was also unsuccessful after 1 year. Subsequently, on switching to oral doxycycline for 6 month...
Source: Skinmed - December 20, 2022 Category: Dermatology Authors: Volha Lenskaya Megan O'Connor Ellen H de Moll Garrett Desman Source Type: research
